Immuron Ltd
IMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660046
No open-market purchases or sales by Immuron Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $82.2K in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Immuron Ltd changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 9 | 7 | −2 |
| Shares | 164.5K | 84.9K | −79.6K (−48.4%) |
| Value | $125.7K | $65.7K | −$60.0K (−47.7%) |
New holders (2)
Institutions that held Immuron Ltd at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 10,906 | $8.45K | 0.00% |
| BlackRock, Inc. | 225 | $174 | 0.00% |
Sold out (4)
Institutions that held Immuron Ltd at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Jane Street Group, LLC | 22,458 | $17.1K |
| Virtu Financial LLC | 11,370 | $9.00K |
| UBS Group AG | 4,143 | $3.16K |
| SBI Securities Co., Ltd. | 10 | $8 |